Does NELARABINE Cause Malignant neoplasm progression? 28 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Malignant neoplasm progression have been filed in association with NELARABINE (Nelarabine). This represents 3.8% of all adverse event reports for NELARABINE.
28
Reports of Malignant neoplasm progression with NELARABINE
3.8%
of all NELARABINE reports
17
Deaths
6
Hospitalizations
How Dangerous Is Malignant neoplasm progression From NELARABINE?
Of the 28 reports, 17 (60.7%) resulted in death, 6 (21.4%) required hospitalization, and 3 (10.7%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NELARABINE. However, 28 reports have been filed with the FAERS database.
What Other Side Effects Does NELARABINE Cause?
Febrile neutropenia (67)
Drug ineffective (50)
Myelopathy (47)
Neurotoxicity (47)
Neuropathy peripheral (45)
Muscular weakness (42)
Sepsis (39)
Peripheral sensory neuropathy (38)
Neutropenia (37)
Off label use (37)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which NELARABINE Alternatives Have Lower Malignant neoplasm progression Risk?
NELARABINE vs NELFINAVIR
NELARABINE vs NELVUTAMIG
NELARABINE vs NEMOLIZUMAB
NELARABINE vs NEMOLIZUMAB-ILTO
NELARABINE vs NEOMYCIN